EFFECTS OF DIFFERENT DIETARY FATS ON PLASMA-LIPID LEVELS.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to L W KINSELL.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Synthetic 8-lysine vasopressin administered as a nasal spray to three patients with diabetes insipidus resulted in excellent control in one. In the other two it was of some value as therapy supplemental to pitressin tannate in oil. The patient who was adequately controlled with "spray therapy" alone required the sprays every three hours during the day, but none during the night.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Seventy-eight patients with mild diabetes were treated with chlorpropamide in doses up to 1 gm. daily. Eight showed primary failure to respond and two showed an initial but not a sustained response. Patients whose diabetes was of recent onset and who had not been treated with insulin or a sulfonylurea, required smaller doses than the remainder except for a group of patients who had been diabetic for more than 15 years. The average dose for the 64 patients who took chlorpropamide for more than three months was 0.46 gm. per day. Serious side effects were uncommon and disappeared when the drug was stopped. One patient became jaundiced, one had a rash, and one showed granulocytopenia. Changes in liver function tests were seen in 17 out of 56 patients treated for more than three months and were correlated with the dosage of the drug and the duration of treatment.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.